ReWalk Robotics Ltd. announced the appointment of Michael Lawless, CPA, as Chief Financial Officer, effective September 19, 2022. Mr. Lawless brings more than 20 years of experience leading finance and investor relations activities at life science and technology companies to drive greater financial discipline, better strategic decision making, and improved access to capital. Mr. Lawless most recently served as a CFO consultant for Danforth Advisors, LLC, where he provided financial and analytical support services to early-stage life science companies.

Prior to joining Danforth Advisors, Mr. Lawless was the CFO of Brooks Life Sciences, a $200 million division of Brooks Automation (now Azenta Inc.). In prior roles, Mr. Lawless also served as the head of Financial Planning and Analysis for Brooks Automation and PerkinElmer Inc., where he led all facets of planning, forecasting, and analysis activities. During his career, he has also led the Investor Relations activities at four public life sciences companies, including Aegerion Pharmaceuticals, PerkinElmer Inc., Momenta Pharmaceuticals, and CTI Molecular Imaging Inc.Mr. Lawless holds a Bachelor of Arts degree in Economics with a Concentration in Public Policy from Swarthmore College and a Master of Business Administration degree from the Tuck School of Business at Dartmouth College.